White (1984) |
Adrenergic Activation |
Human |
Prophylactic use of timolol after CABG decreases frequency and severity of supraventricular arrhythmias. |
Kalman (1995) |
Adrenergic Activation |
Human |
Significant association between norepinephrine levels and the development of POAF |
Bruins (1997) |
Inflammation |
Human |
The second phase of complement activation during CPB involves CRP and is associated with POAF |
Frustaci (1997) |
Inflammation |
Human |
Lymphomononuclear infiltrates compatible with atrial myocarditis in atrial tissue of 66% of patients with lone AF |
Carnes (2001) |
Oxidative stress |
Canine/human |
Ascorbate attenuates rapid pacing-induced atrial ERP shortening and decreases the incidence of POAF after CABG. |
Kumagai (2004) |
Inflammation/oxidative stress |
Canine |
Atorvastatin prevents AF by inhibiting inflammation in the sterile pericarditis model |
Shiroshita-Takeshita (2004) |
Oxidative Stress/inflammation |
Canine |
AF promotion by atrial tachycardia is attenuated by simvastatin, but not by antioxidant vitamins. |
Ishii (2005) |
Inflammation |
Canine |
Atrial inflammation after cardiac surgery is associated with inhomogeneity of atrial conduction |
Workman (2006) |
Adrenergic activation |
Human |
Chronic β-blocker therapy is associated with reduced POAF incidence, unrelated to pre-operative ERP-prolonging |
Kim (2008) |
Oxidative stress |
Human |
NADPH oxidase activity in right atrial appendage is the most important independent predictor of POAF. |
Fleming (2008) |
Adrenergic Activation |
Human |
Perioperative milrinone use is associated with an increased incidence of POAF |
Ozaydin (2008) |
Oxidative stress |
Human |
Treatment with N-acetylcysteine, an antioxidant, decreases the incidence of post-operative AF. |
Ho (2009) |
Inflammation |
Human |
Corticosteroid prophylaxis is effective in reducing the risk of atrial fibrillation |